Pharma Journalist -

Cerecor Inc. and TRx Pharmaceuticals, LLC (TRx) announced that the companies have entered into a purchase agreement in which Cerecor will acquire TRx, including subsidiary Zylera…
Read More...

Samsung Bioepis Co., Ltd. announced the European Commission’s (EC) marketing authorization of ONTRUZANT, a biosimilar referencing Herceptin (trastuzumab), for the treatment of early…
Read More...

AVEO Oncology announced the appointment of Nikhil Mehta, Ph.D., as Senior Vice President of Regulatory and Quality Assurance, effective November 20, 2017. In this role, Dr. Mehta will…
Read More...

Revance Therapeutics announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for the Company’s product candidate, DaxibotulinumtoxinA for Injection…
Read More...

AstraZeneca announced that the US Food and Drug Administration (FDA) has approved a new indication for Faslodex(fulvestrant), expanding the indication to include use with abemaciclib, a…
Read More...

Cue Biopharma announced a strategic research collaboration and license agreement with Merck, known as MSD outside of the United States and Canada. Under the terms of the deal, the CUE…
Read More...

TESARO announced that the European Commission (EC) has granted marketing authorization for ZEJULA®(niraparib) as a monotherapy for the maintenance treatment of adult patients with…
Read More...

kaléo announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for AUVI-Q®(epinephrine injection, USP) 0.1 mg, the first and…
Read More...

WuXi AppTec announced that its Advanced Therapy Unit based in Philadelphia has been selected as a manufacturing partner for advanced therapies through the California Institute for…
Read More...

PeptiDream Inc., a public Kanagawa-based biopharmaceutical company announced that it has entered into a multi-target discovery collaboration with Germany-based Bayer AG. Under the…
Read More...